Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances

Eur J Pharmacol. 2024 Apr 15:969:176452. doi: 10.1016/j.ejphar.2024.176452. Epub 2024 Feb 28.

Abstract

Seeking an effective and safe scheme is the common goal of clinical treatment of tumor patients. In recent years, traditional Chinese medicine has attracted more and more attention in order to discover new drugs with good anti-tumor effects. Oroxylin A (OA) is a compound found in natural Oroxylum indicum and Scutellaria baicalensis Georgi plants and has been used in the treatment of various cancers. Studies have shown that OA has a wide range of powerful biological activities and plays an important role in neuroprotection, anti-inflammation, anti-virus, anti-allergy, anti-tumor and so on. OA shows high efficacy in tumor treatment. Therefore, it has attracted great attention of researchers all over the world. This review aims to discuss the anti-tumor effects of OA from the aspects of cell cycle arrest, induction of cell proliferation and apoptosis, induction of autophagy, anti-inflammation, inhibition of glycolysis, angiogenesis, invasion, metastasis and reversal of drug resistance. In addition, the safety and toxicity of the compound were also discussed. As a next step, to clarify the benefits and adverse effects of Oroxylin A in cancer patients further experiments, especially clinical trials, are needed.

Keywords: Apoptosis; Cancer; Metastasis; Molecular mechanisms; Oroxylin A; Traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Autophagy
  • Cell Proliferation
  • Flavonoids* / pharmacology
  • Flavonoids* / therapeutic use
  • Humans
  • Neoplasms* / drug therapy

Substances

  • 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
  • Flavonoids